Rozlytrek as monotherapy is indicated for the treatment of adult patients with ROS1 positive, advanced non small cell lung cancer (NSCLC) not previously treated with ROS1 inhibitors.
Packaging DetailsEntrectinib is used to treat metastatic (lung cancer that has already spread) non-small cell lung cancer (NSCLC) that is caused by a gene called ROS1.
Member Since 1 Year
Nature of Business Manufacturer
GST No. 37AAECL4415B1ZX
For Buyer 
For Seller 
Help 
Visalakshi Nagar, Visakhapatnam, Andhra Pradesh 
Send Enquiry